Valye reports for unlimited access

MSC Income Fund, Inc. operates as a regulated investment company under U.S. federal tax laws applicable to RICs. It distributes dividends payable in cash or stock, with tax consequences for stockholders. The Fund invests in a portfolio of companies and is exposed to various market, economic, and operational risks. It maintains a cybersecurity program to manage information technology risks. The Fund's financial results and operations are influenced by general economic conditions, regulatory changes, and technological innovation. Recent leadership changes and analyst coverage provide additional context on its business environment.

Host Hotels & Resorts, Inc. is a lodging real estate investment trust (REIT) focusing on luxury and upper-upscale hotels primarily in the United States, with a small portion of revenues from Canada and Brazil. The company owns hotels operated by third-party managers under long-term agreements, who earn fees based on hotel revenues and profitability. The business model generates revenues mainly from rooms, food and beverage, and other ancillary services. Operating expenses are largely hotel-level costs including labor, management fees, property taxes, and depreciation. Key performance indicators include occupancy, average daily rate, and revenues per available room. The company supplements GAAP financials with non-GAAP measures such as NAREIT Funds From Operations (FFO) and EBITDAre to evaluate profitability and operating performance [S1].

CB Financial Services, Inc. is a publicly reporting company with recent SEC filings providing financial data through mid-2026. The company reported strong liquidity with cash and equivalents of $76.09 million and a cash ratio of 4.71 as of June 30, 2026. Net income for Q2 2026 was $4.301 million with basic and diluted EPS of $0.85 and $0.80 respectively. Recent news coverage highlights the company surpassing Q2 earnings and revenue expectations and receiving positive analyst coverage. The company has also experienced some quarters with earnings below expectations, indicating variability in performance.

Construction Partners, Inc. specializes in civil infrastructure construction and maintenance, primarily focusing on roadways in the Sunbelt region of the United States. The company operates a vertically integrated model encompassing hot mix asphalt production, paving, site development, aggregate mining, and liquid asphalt distribution. It serves both public and private sectors, with a significant portion of revenues derived from state Departments of Transportation and other government agencies. The company manages a substantial contract backlog and pursues growth through acquisitions and strategic initiatives outlined in its ROAD 2030 plan.

Enterprise Products Partners L.P. is a midstream energy partnership operating a diversified portfolio of assets including pipelines, processing plants, fractionation facilities, and storage terminals. The company primarily serves the U.S. Gulf Coast and other key regions, providing services for natural gas, NGLs, crude oil, petrochemicals, and refined products. Its business model depends on volumes transported and processed, which are influenced by commodity prices, production levels, and demand for hydrocarbon products. The partnership structure entails specific governance and tax considerations for unitholders.

CF BANKSHARES INC. is a financial holding company primarily engaged in banking through its subsidiary CFBank, NA. The company operates in local markets, attracting deposits through competitive interest rates and customer service. It manages liquidity via cash holdings, credit facilities, and borrowing capacity from the Federal Home Loan Bank and Federal Reserve Bank. The company services subordinated debt and maintains a stock repurchase program authorized by its Board of Directors. Dividend payments are subject to regulatory approval and depend on liquidity and earnings at both the holding company and bank levels. The company’s financial disclosures include detailed information on debt service obligations, credit facilities, and capital resources.

YUNHONG GREEN CTI LTD. operates as a publicly listed company with filings indicating a structured corporate governance and compliance with SEC reporting requirements. The company maintains liquidity with a current ratio above 1, though cash on hand is limited relative to liabilities. The firm reported a net loss in the most recent quarter. Market coverage over the years shows fluctuating investor interest and stock price movements.

Spectrum Brands Holdings, Inc. is a diversified consumer products company operating primarily in three segments: Global Pet Care (GPC), Home & Garden (H&G), and Home and Personal Care (HPC). The company monitors organic net sales to assess segment performance, excluding currency effects and acquisitions. Recent financial disclosures show growth in GPC and H&G segments, while HPC has experienced some declines. The company has undertaken a strategic investment transaction in HPC with Oaktree Capital Management, which holds a minority equity stake. Spectrum Brands is engaged in a multi-year global ERP transformation project to upgrade its enterprise systems. The company faces ongoing challenges from U.S. tariffs and geopolitical conflicts, which have increased costs and supply chain risks. It employs mitigation strategies including pricing adjustments, supply chain diversification, and cost management. Liquidity remains strong with substantial cash reserves and credit availability. The company pays quarterly dividends and has reduced total dividend payments due to share repurchases.

Norwood Financial Corp operates as a financial institution primarily serving its local geographic market areas. Its loan portfolio includes a mix of consumer loans, commercial real estate loans, construction loans, and municipal finance loans. The company maintains underwriting policies that limit risk exposure, including restrictions on certain loan types and requirements for insurance coverage. The company completed a public offering in December 2024, raising net proceeds of approximately $28 million, which were used to reposition its debt securities portfolio to improve profitability, liquidity, and capital position. As of year-end 2025, total assets were approximately $2.425 billion, with loans receivable totaling about $1.853 billion. The allowance for credit losses was $19.9 million, representing 1.07% of total loans. The company offers an Automatic Dividend Reinvestment Plan to shareholders. Recent financial results for Q2 2026 show net income of $9.3 million and EPS of $0.86. The company has been the subject of recent news coverage focusing on earnings calls, dividend yields, and insider buying.

John Marshall Bancorp, Inc. is a Virginia-based bank holding company for John Marshall Bank, which operates primarily in the Washington, D.C. metropolitan area. The company focuses on serving small to medium-sized businesses, professional services, non-profits, and individuals with a comprehensive suite of banking products including commercial loans, deposit accounts, treasury management, SBA 7(a) loans, and digital banking services. The bank operates eight full-service branches across its contiguous market area, which includes counties in Virginia and Maryland as well as the District of Columbia. The company emphasizes a disciplined credit culture, conservative balance sheet management, and a customer-centric approach to compete effectively against larger regional and national banks. The company’s strategy includes organic growth through hiring experienced commercial bankers, selective market expansion, and leveraging technology to maintain a branch-lite footprint. The Washington, D.C. MSA market is characterized by strong economic fundamentals, population growth, and banking consolidation, providing opportunities for the company to gain market share by serving customers seeking personalized service.

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative medicines primarily in oncology, with a lead candidate (Z)-endoxifen targeting estrogen receptor positive breast cancer and other breast conditions. The company holds patents covering (Z)-endoxifen through at least 2038 and is advancing multiple Phase 2 clinical trials evaluating its efficacy and safety in breast cancer treatment and prevention settings. Beyond oncology, (Z)-endoxifen is being explored for rare diseases such as Duchenne Muscular Dystrophy and McCune-Albright Syndrome, with FDA designations supporting these indications. The company has proprietary manufacturing capabilities and is supported by qualified suppliers. Financially, Atossa has incurred operating losses and holds cash reserves but faces liquidity challenges without established revenue streams. The company plans to raise additional capital to fund ongoing operations and clinical development. Risks include clinical trial outcomes, regulatory approvals, capital availability, competition, and intellectual property protection [S1][S2].

Kiora Pharmaceuticals is focused on developing innovative ophthalmic pharmaceutical products targeting retinal diseases. Its lead asset, KIO-301, is a novel photoswitch molecule designed to restore vision in patients with inherited and age-related retinal degenerative diseases such as retinitis pigmentosa. KIO-301 completed Phase 1b trials demonstrating safety and vision improvements and is currently in a Phase 2 trial enrolling patients with ultra-low vision. KIO-104, a potent DHODH inhibitor, targets retinal inflammatory diseases including diabetic macular edema and posterior non-infectious uveitis, with Phase 2 trials underway. KIO-101, a topical formulation of the same API as KIO-104, is being developed for ocular manifestations of autoimmune diseases, with partnership efforts ongoing. The company has entered strategic collaborations to support development and commercialization, including a global agreement with Théa Open Innovation and an option agreement with Senju Pharmaceutical for Asian markets. Kiora is a clinical-stage company with no commercial products or revenue, financing operations through equity offerings, collaborations, and private placements.

DraftKings Inc operates as a digital sports entertainment and gaming company providing online and retail sports betting, online casino gaming, daily fantasy sports, digital lottery courier services, and prediction markets. The company focuses on creating engaging real-money gaming experiences while maintaining strong regulatory compliance and consumer protection. Its business model involves launching product offerings in new U.S. jurisdictions with significant upfront investment in customer acquisition and retention until achieving critical mass. DraftKings leverages scalable technology to expand efficiently and aims to improve profitability through increased revenue, gross profit, and operational efficiencies. Key performance metrics include Monthly Unique Payers, Average Revenue per MUP, Sportsbook Handle, and Sportsbook Net Revenue Margin. The company reported $6.05 billion in revenue for 2025, with growth driven by Sportsbook and iGaming segments, and maintains a focus on expanding its user base and product offerings.

AGM Group Holdings, Inc. operates as an integrated technology company focused on blockchain-oriented ASIC chip design, cryptocurrency mining machines, and financial technology software services. The company derives its revenue primarily from sales of cryptocurrency mining machines and standardized computing equipment, recognizing revenue upon transfer of control to customers. In 2025, AGM developed the KOI MINER C21 SERIES, a proprietary ASIC mining machine with high hash rate and energy efficiency. The company also divested a subsidiary, Nanjing Lucun, in 2025, which was accounted as discontinued operations. AGM has expanded into AI infrastructure with the launch of the ValleyVerse Kraken clustered storage server and has entered the real-world asset tokenization market through a strategic memorandum of understanding. The company has secured financing through a $25 million equity line of credit and convertible advances to support its growth initiatives [S1][N1][N2][N3][N4][N5].

Starz Entertainment Corp. is a Canadian-based company focused on premium subscription video services distributed primarily in the U.S. via OTT platforms and traditional multichannel video programming distributors. The company operates the Starz branded service, offering content through direct-to-consumer apps and wholesale distribution. Starz completed a corporate separation from Lions Gate Entertainment Corp. in May 2025, becoming an independent publicly traded company. The company manages its operations through a single reportable segment, Starz Networks, which includes U.S. and Canadian operations. Starz has exclusive licensing agreements with New Lionsgate and Universal for film content. The company has been undertaking strategic content reviews and restructuring to adjust its content portfolio in response to evolving industry dynamics and economic conditions. Starz's revenue streams include OTT subscription revenue and linear and other revenue, with recent periods showing declines in revenue and increased operating losses. The company maintains liquidity through cash flow from operations, credit facilities, monetization of trade receivables, and programming related obligations.

ARKO Corp. is a Delaware-based company operating through consolidated subsidiaries primarily in the fuel and merchandise retail and wholesale sectors. The company generates significant revenue from fuel sales and merchandise, with operating expenses closely aligned to these revenue streams. ARKO is engaged in a multi-year transformation plan including converting retail stores to dealer locations and has recently launched an IPO for its subsidiary ARKO Petroleum Corp. The company operates in a highly competitive and fragmented industry and faces various operational, regulatory, and market risks.

News Corp is a media and publishing company generating revenue through content creation, distribution, and related services. The company’s financial disclosures for fiscal year 2026 show solid revenue and profitability metrics, supported by a healthy liquidity position. News Corp regularly reports quarterly earnings and holds conference calls to discuss performance and strategic initiatives. Recent quarters have demonstrated growth in core business segments and increased revenues compared to prior periods.

Nathan's Famous, Inc. is primarily engaged in marketing the Nathan's Famous brand and selling products bearing its trademarks through multiple channels. The company operates and franchises quick-service restaurants featuring its signature beef hot dogs and other menu items. It also sells packaged products through supermarkets and foodservice operators under licensing and branded product programs. The restaurant system includes Company-owned and franchised locations, including virtual kitchens, across the United States and internationally. The company focuses on expanding distribution and market penetration across its business platforms. Revenues are mainly derived from the Licensing Program, Branded Product Program, Company-owned restaurants, and franchise royalties. The company faces inflationary pressures on commodity prices and labor costs, competitive labor market challenges, and regulatory impacts such as minimum wage increases. Nathan's is in the process of being acquired by Smithfield Foods, which will result in it becoming a wholly owned subsidiary and ceasing to be publicly traded upon completion of the merger.

Boundless Bio, Inc. operates as a clinical-stage biopharmaceutical company specializing in oncology drug development. Its pipeline includes BBI-355, a selective CHK1 inhibitor in Phase 1/2 trials targeting replication stress in cancers, and BBI-940, a novel Kinesin degrader selected for development after preclinical success. The company has undergone portfolio prioritization and operational streamlining, including workforce reduction, to extend its financial runway. In June 2026, Boundless Bio merged with Serapha Bio, supported by a $230 million private placement. The company maintains strong liquidity with significant cash and short-term investments as of mid-2026. It has also restructured leadership and shifted strategic focus to advance its oncology programs.

Canopy Growth Corp operates in the cannabis industry, focusing on building a global infrastructure to capitalize on cannabis market opportunities. The company has experienced significant losses and negative cash flow in recent years and is in the process of remediating a material weakness in internal controls related to financial reporting. It holds licenses under Canadian excise duty frameworks and is subject to complex regulatory environments, including U.S. federal cannabis laws that affect its operations and listing status. Canopy Growth relies on third-party manufacturers and distributors, which introduces operational risks. The company has made recent acquisitions that may pose integration challenges. It faces risks from cybersecurity threats, regulatory investigations, and evolving market conditions. Liquidity as of June 30, 2026, is strong with a current ratio of 3.04 and cash ratio of 2.02. The company continues to invest in its business and manage growth challenges typical of developing enterprises [S1][S2].

Republic Services, Inc. operates primarily in the environmental services sector, providing waste collection, transfer, recycling, and disposal services across the United States and Canada. The company manages numerous landfills and landfill gas-to-energy projects, contributing to renewable energy production. It is subject to federal and state environmental regulations, including greenhouse gas emission standards and landfill methane regulations. The company has a significant debt load and invests in technology, including AI, to enhance operational efficiency and customer engagement. Its business model involves managing environmental liabilities, regulatory compliance, and leveraging technology to maintain competitive positioning.

Red Rock Resorts, Inc. is a holding company primarily engaged in the gaming industry, operating casino properties mainly in the Las Vegas metropolitan area and managing Native American gaming arrangements. The company’s business model centers on gaming revenues, which constitute the majority of its income, with slot machine play accounting for approximately 80% of casino revenue. Non-gaming revenues include food and beverage, hotel room rentals, and other entertainment amenities. The company’s operations are capital intensive, relying on cash flows generated from gaming and related services to fund debt service and capital expenditures. Red Rock Resorts consolidates its financial results from Station Holdco and Station LLC, entities through which it conducts its operations. The company’s customer base is largely local, with economic conditions in the Las Vegas area influencing business performance. The company’s financial statements are prepared under GAAP and audited by Ernst & Young LLP, with detailed disclosures on goodwill, intangible assets, debt maturities, and risk factors. The company actively manages interest rate risk through hedging instruments and maintains an equity repurchase program authorized up to $900 million.

HA Sustainable Infrastructure Capital, Inc. (HASI) is an investment firm dedicated to sustainable infrastructure assets that support the energy transition. The company focuses on income-generating real assets with long-term recurring cash flows, investing primarily in three markets: Behind the Meter (BTM), Grid-Connected (GC), and Fuels, Transport, and Nature (FTN). HASI has completed over 1,300 investments since 1998 and manages over $16 billion in assets as of March 31, 2026. The company emphasizes long-term client relationships, access to permanent capital, and investing in smaller transaction sizes to increase opportunities. HASI also measures the environmental impact of its investments through its CarbonCount® metric, estimating significant annual CO2 emissions avoided. The company is internally managed with a team of over 170 professionals and maintains strong margins across interest rate cycles. As of Q2 2026, HASI reported $120.8 million in revenue and $128.6 million in net income, with a substantial pipeline of potential investments exceeding $6.5 billion [S1][S2].

Natera, Inc. develops and commercializes proprietary molecular diagnostic tests using cell-free DNA technology combined with advanced bioinformatics. The company focuses on three main healthcare areas: oncology, women's health, and organ health. Its oncology portfolio includes personalized ctDNA tests such as Signatera for molecular residual disease detection and monitoring, and Latitude for colorectal cancer MRD without tumor tissue. In women's health, Natera offers Panorama, a leading non-invasive prenatal test screening for chromosomal abnormalities and microdeletions, and Empower, a hereditary cancer screening test. Organ health products assess transplant rejection and genetic kidney disease. Natera operates CLIA-certified laboratories in the U.S. and distributes products globally through a network of over 100 partners. The company supports clinical adoption through integrated commercial, medical, and operational capabilities, including direct sales, medical affairs, and digital tools for patient and provider support. Natera maintains a strong intellectual property portfolio with over 650 patents and emphasizes clinical evidence generation with over 350 peer-reviewed publications. The company faces competition from established and emerging molecular diagnostics firms across its segments and is subject to extensive regulatory and reimbursement environments.

10x Genomics develops and sells advanced life sciences research tools focused on single cell and spatial analysis. Its product portfolio includes instruments such as Chromium, Visium CytAssist, and Xenium Analyzer, along with proprietary consumables and bundled software to support biological research workflows. The company derives revenue from product sales, including instruments and consumables, as well as post-warranty service contracts. It operates globally with significant revenue from the Americas, Europe, and Asia-Pacific regions. The company has pursued acquisitions to enhance its technology offerings, including the recent acquisition of Proteintech Genomics, which expands its proteomics capabilities.

Westrock Coffee Company operates as an integrated provider of coffee, tea, flavors, extracts, and ingredients solutions, offering end-to-end services from sourcing and supply chain management to product development, roasting, packaging, and distribution. The company serves a broad customer base including retail, food service, convenience stores, CPG, and hospitality sectors. Its business model is built on four pillars: transparent supply chain, innovative beverage solutions, comprehensive product offerings, and a scaled international presence. Westrock’s proprietary technology enables digital traceability from farm to finished product, supporting sustainability and responsible sourcing initiatives. The company’s product portfolio spans multiple beverage categories and packaging formats, with a focus on innovation in liquid extracts and RTD beverages. Growth strategies include product innovation, customer base expansion, geographic growth aligned with customer locations, acquisitions, and margin improvement through scale and product mix. The company faces competition from established and emerging players across its product lines and geographies.

First United Corporation is a financial services company with operations in community banking, wealth management, trust services, and brokerage commissions. The company regularly files detailed SEC reports, including quarterly 10-Q filings and annual 10-K filings, which provide insight into its financial performance and business segments. Recent leadership changes include the appointment of a new CEO in late 2025. The company has a focus on dividend payments and growth, as reflected in recent news coverage.

Strawberry Fields REIT, Inc. is a real estate investment trust focused on owning skilled nursing facility properties in the United States. The company leases these properties to tenants/operators who provide healthcare services subject to federal and state licensure, certification, and regulatory compliance. The business model depends on maintaining compliant tenants and managing properties in accordance with healthcare industry standards and environmental regulations. The company is classified as an emerging growth company and files periodic reports with the SEC. It has a relatively small employee base and maintains insurance coverage through its tenants. Legal proceedings related to prior acquisitions have been dismissed with prejudice as of early 2026. Financial disclosures indicate positive net income and cash balances as of mid-2026 [S1][S2].

Outset Medical, Inc. develops and markets medical devices for dialysis treatment, with a focus on the Tablo Hemodialysis System. The company has obtained FDA 510(k) clearance for its products and is engaged in ongoing product development and regulatory compliance activities. Its business model centers on providing innovative dialysis solutions to healthcare providers. The company reported a net loss in the most recent quarter but maintains strong liquidity. Regulatory compliance and manufacturing quality are critical operational areas subject to FDA oversight.

Nature's Sunshine Products Inc is a Utah-based natural health and wellness company established in 1976. It manufactures and sells over 800 nutritional and personal care products across multiple categories including general health, immune support, cardiovascular, digestive, personal care, and weight management. The company operates through four geographic segments: Asia, Europe, North America, and Latin America and Other, selling primarily under the Nature's Sunshine Products and Synergy WorldWide brands. Distribution is conducted mainly via a network of independent consultants who market products directly to consumers. The company emphasizes product quality, regulatory compliance, and consultant support through training and incentives. Manufacturing is primarily done at its Utah facility with some contract manufacturing. The company faces competition from larger firms and other direct selling companies in the nutritional and personal care space. It is subject to extensive U.S. and international regulations governing product safety, labeling, advertising, and direct selling practices.

Charlton Aria Acquisition Corp is a Cayman Islands exempted blank check company formed to effect a merger or similar business combination with one or more target businesses. It completed its IPO in October 2024, raising $75 million, with proceeds held in a trust account invested in U.S. government securities. The company has no operations or revenue and is classified as a shell company. Its management focuses on identifying target businesses with strong management, growth potential, and defensible market positions, aiming to leverage the benefits of being a U.S. public company. The company must complete its initial business combination by October 25, 2026, following two deadline extensions funded by the sponsor. Liquidity as of June 30, 2026, is limited relative to liabilities, and the company has incurred losses from formation and operating costs. Nasdaq has issued notices for late SEC filings, with a plan submitted to regain compliance. The company currently has one executive officer and maintains offices in Wilmington, Delaware.

Cable One, Inc. operates in the cable television and broadband services sector, providing residential and business data services primarily in the United States. The company generates revenue through subscription fees for its cable and internet services. It manages a capital-intensive business with significant investments in network infrastructure and technology platforms. Cable One uses Adjusted EBITDA as a key performance metric to assess operating results, excluding non-cash and special items. The company has recently completed strategic transactions including acquiring remaining equity interests in Mega Broadband Investments Holdings LLC (MBI) and is actively managing related debt refinancing. Its financial position as of mid-2026 shows substantial indebtedness alongside liquidity resources. The company faces competitive pressures, technological changes, regulatory risks, and operational challenges including cybersecurity and vendor supply risks as disclosed in its SEC filings [S1][S2].

Citigroup Inc is a diversified bank operating within the financial services sector. It offers a broad range of banking and financial products and services globally. The company reports detailed financial results annually and quarterly, with the latest full-year data for 2025 and Q2 2026 filings available. Its business segments include consumer banking, commercial banking, markets, wealth management, and corporate services.

Shoulder Innovations, Inc. operates exclusively in the shoulder surgical care market, focusing on shoulder arthroplasty procedures. Its product ecosystem includes advanced implant systems for anatomic and reverse total shoulder arthroplasty, a proprietary AI/ML-enabled preoperative planning platform (ProVoyance), a streamlined two-tray instrument system, and specialized surgeon support and collaboration networks. The company aims to address clinical and operational challenges in shoulder surgery by improving implant fixation, procedural efficiency, and patient outcomes. It targets both hospital and outpatient settings, with particular emphasis on ambulatory surgery centers due to their cost-efficiency and growth potential. The company has FDA clearances for its devices and a growing clinical evidence base supporting its implant technologies. Commercially, it leverages a dedicated leadership team, medical education initiatives, and a network of independent distributors to drive adoption. Financially, the company reported $17.175 million in revenue and a net loss of $10.153 million for Q2 2026, with strong liquidity metrics as of June 30, 2026. It faces competition from major orthopedic device manufacturers and supply chain risks related to reliance on single-source suppliers.

Ouster, Inc. operates in the technology sector within the electronic components industry, focusing on Physical Artificial Intelligence (Physical AI) through advanced sensing and perception technologies. The company develops and markets a unified platform that integrates digital lidar sensors, cameras, AI compute, sensor fusion, and perception software to enable autonomous machine operation across multiple industries. Ouster's four primary markets are industrial automation, smart infrastructure, robotics, and automotive, each leveraging lidar technology for safety, efficiency, and autonomy. The product portfolio includes the OS scanning lidar series with multiple models and configurations, the DF solid-state flash lidar series designed for automotive ADAS and other applications, and perception platforms such as Ouster Gemini and BlueCity for security and traffic management. Ouster has expanded its capabilities through acquisitions of Sense Photonics, Velodyne Lidar, and Stereolabs, enhancing its hardware and software offerings. The company maintains a strong intellectual property portfolio covering its digital lidar architecture, custom system-on-a-chip, VCSEL laser arrays, and micro-optical systems. Manufacturing partnerships with Benchmark Electronics and Fabrinet support scalable production. Financially, as of mid-2026, Ouster holds substantial cash and investments with a strong liquidity profile but continues to report net losses in recent quarters [S1][S2].

ICF International, Inc. provides professional services and technology-based solutions primarily to government and commercial clients worldwide. Its services span advisory, program implementation, analytics, digital, and engagement areas, addressing complex challenges in energy, environment, infrastructure, disaster recovery, health and social programs, and security. The company operates globally with approximately 8,400 employees and maintains a broad client base including U.S. federal, state, local, and international governments, as well as commercial entities. ICF emphasizes multi-disciplinary teams, proprietary analytics, and technology-enabled solutions such as AI and cloud platforms to deliver tailored, cost-effective services. The company reported revenues near $1.9 billion in 2025 and maintains a substantial backlog, reflecting ongoing demand across its markets.